Literature DB >> 24464647

Concomitant evaluation of PMA+ionomycin-induced kinase phosphorylation and cytokine production in T cell subsets by flow cytometry.

Timothy Q Crawford1, Emilie Jalbert, Lishomwa C Ndhlovu, Jason D Barbour.   

Abstract

Methods to detect intracellular kinase signaling intermediates by flow cytometry have been recently developed. Termed "phospho-flow," these methods employ fluorescence-conjugated monoclonal antibodies that recognize phosphorylated epitopes of intracellular kinases, and may be combined with surface phenotypic markers to observe changes in kinase pathways by cellular subset. Effector functions, like cytokine production, are processes intrinsically linked to intracellular signaling and kinase activity within each cell. Methodologies that would simultaneously detect changes to signaling pathways as well as effector responses at the single-cell level would allow for mapping of the functional consequences induced by signaling pathway modifications. However, there are challenges to developing such a combined protocol, relating to the different kinetics of rapid signaling events and the more prolonged time required to induce and observe cytokine responses. In this report, we describe the development of an assay that accommodates differences in protocol conditions and response kinetics, merging phospho-flow cytometry, and intracellular cytokine staining methods into a single experimental protocol. We examined intracellular ERK1/2 phosphorylation and IFN-γ production by CD4+ and CD8+ T cells upon polyclonal stimulation with PMA and ionomycin, while monitoring expression of the cytolytic molecule perforin and the T cell activation marker CD38. We present a method that allows observation of kinase phosphorylation and cytokine production within the same cell after stimuli, while maintaining a stable cellular phenotype. Monitoring of signaling and effector functions in distinct immune subsets provides a platform to investigate and relate intracellular kinase signaling activity to immune cell effector function and phenotype in disease states.
© 2014 International Society for Advancement of Cytometry.

Entities:  

Keywords:  CD38; ERK; HLA-DR; ICS; IFN-γ; T cell; immune effector function; perforin; phosflow; phospho-flow intracellular cytokine staining

Mesh:

Substances:

Year:  2014        PMID: 24464647     DOI: 10.1002/cyto.a.22444

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  7 in total

1.  Baseline T-lymphocyte and cytokine indices in sheep peripheral blood.

Authors:  Jihui Yang; Yongxue Lv; Yazhou Zhu; Shasha Li; Jia Tao; Liangliang Chang; Mingxing Zhu; Jiaqing Zhao; Yana Wang; Changyou Wu; Wei Zhao
Journal:  BMC Vet Res       Date:  2022-05-05       Impact factor: 2.792

2.  4,5-Disubstituted 1,2,3-triazoles: Effective Inhibition of Indoleamine 2,3-Dioxygenase 1 Enzyme Regulates T cell Activity and Mitigates Tumor Growth.

Authors:  Subhankar Panda; Nirmalya Pradhan; Soumya Chatterjee; Sudhir Morla; Abhishek Saha; Ashalata Roy; Sachin Kumar; Arindam Bhattacharyya; Debasis Manna
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

3.  Reactivating latent HIV with PKC agonists induces resistance to apoptosis and is associated with phosphorylation and activation of BCL2.

Authors:  Andrea J French; Sekar Natesampillai; Ashton Krogman; Cristina Correia; Kevin L Peterson; Alecia Alto; Aswath P Chandrasekar; Anisha Misra; Ying Li; Scott H Kaufmann; Andrew D Badley; Nathan W Cummins
Journal:  PLoS Pathog       Date:  2020-10-19       Impact factor: 6.823

4.  An Artifact in Intracellular Cytokine Staining for Studying T Cell Responses and Its Alleviation.

Authors:  Zheng Gong; Qing Li; Jiayuan Shi; Guangwen Ren
Journal:  Front Immunol       Date:  2022-01-21       Impact factor: 7.561

5.  MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.

Authors:  Manu Prasad; Jonathan Zorea; Sankar Jagadeeshan; Avital B Shnerb; Sooraj Mathukkada; Jebrane Bouaoud; Lucas Michon; Ofra Novoplansky; Mai Badarni; Limor Cohen; Ksenia M Yegodayev; Sapir Tzadok; Barak Rotblat; Libor Brezina; Andreas Mock; Andy Karabajakian; Jérôme Fayette; Idan Cohen; Tomer Cooks; Irit Allon; Orr Dimitstein; Benzion Joshua; Dexin Kong; Elena Voronov; Maurizio Scaltriti; Yaron Carmi; Cristina Conde-Lopez; Jochen Hess; Ina Kurth; Luc G T Morris; Pierre Saintigny; Moshe Elkabets
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 12.469

6.  NKT-like (CD3 + CD56+) cells differ from T cells in expression level of cellular protective proteins and sensitivity to stimulation in the process of ageing.

Authors:  Lucyna Kaszubowska; Jerzy Foerster; Zbigniew Kmieć
Journal:  Immun Ageing       Date:  2022-04-11       Impact factor: 6.400

7.  The RNA-Binding Protein, Polypyrimidine Tract-Binding Protein 1 (PTBP1) Is a Key Regulator of CD4 T Cell Activation.

Authors:  James La Porta; Rodrigo Matus-Nicodemos; Aníbal Valentín-Acevedo; Lori R Covey
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.